Faculty

Back to Index
Shao-Yao Ying, PhD
Professor of Cell & Neurobiology
Integrative Anatomical Sciences
BMT 303 1333 San Pablo Street Health Sciences Campus Los Angeles
+1 323 442 1859

Publications

Gene Silencing In Vitro and In Vivo Using Intronic MicroRNAs. Methods Mol Biol. 2015; 1218:321-40. View in: PubMed

MiRNA Targets of Prostate Cancer. Methods Mol Biol. 2013; 936:357-69. View in: PubMed

Isolation and Identification of Gene-Specific MicroRNAs. Methods Mol Biol. 2013; 936:271-8. View in: PubMed

Identify Intronic MicroRNA with Bioinformatics. Methods Mol Biol. 2013; 936:77-82. View in: PubMed

The MicroRNA. Methods Mol Biol. 2013; 936:1-19. View in: PubMed

Gene Silencing In Vitro and In Vivo Using Intronic MicroRNAs. Methods Mol Biol. 2013; 936:209-29. View in: PubMed

Mechanism and Method for Generating Tumor-Free iPS Cells Using Intronic MicroRNA miR-302 Induction. Methods Mol Biol. 2013; 936:295-312. View in: PubMed

Transgene-Like Animal Models Using Intronic MicroRNAs. Methods Mol Biol. 2013; 936:279-94. View in: PubMed

A novel role of miR-302/367 in reprogramming. Biochem Biophys Res Commun. 2012 Jan 6; 417(1):11-6. View in: PubMed

Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Res. 2011 Feb; 39(3):1054-65. View in: PubMed

MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways. Cancer Res. 2010 Nov 15; 70(22):9473-82. View in: PubMed

Intron-mediated RNA interference, intronic microRNAs, and applications. Methods Mol Biol. 2010; 629:205-37. View in: PubMed

Intron-mediated RNA interference and microRNA biogenesis. Methods Mol Biol. 2009; 487:387-413. View in: PubMed

Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA. 2008 Oct; 14(10):2115-24. View in: PubMed

The microRNA (miRNA): overview of the RNA genes that modulate gene function. Mol Biotechnol. 2008 Mar; 38(3):257-68. View in: PubMed

Loss of mir-146a function in hormone-refractory prostate cancer. RNA. 2008 Mar; 14(3):417-24. View in: PubMed

Androgen receptor regulates CD168 expression and signaling in prostate cancer. Carcinogenesis. 2008 Feb; 29(2):282-90. View in: PubMed

Intron-mediated RNA interference and microRNA (miRNA). Front Biosci. 2008; 13:2216-30. View in: PubMed

Hyaluronan stimulates transformation of androgen-independent prostate cancer. Carcinogenesis. 2007 Feb; 28(2):310-20. View in: PubMed

Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis. Exp Biol Med (Maywood). 2006 May; 231(5):534-44. View in: PubMed

Transcriptional control of Shh/Ptc1 signaling in embryonic development. Gene. 2006 Feb 15; 367:56-65. View in: PubMed

Current perspectives in intronic micro RNAs (miRNAs). J Biomed Sci. 2006 Jan; 13(1):5-15. View in: PubMed

The microRNA: overview of the RNA gene that modulates gene functions. Methods Mol Biol. 2006; 342:1-18. View in: PubMed

Isolation and identification of gene-specific microRNAs. Methods Mol Biol. 2006; 342:313-20. View in: PubMed

Transgene-like animal models using intronic microRNAs. Methods Mol Biol. 2006; 342:321-34. View in: PubMed

Intronic microRNA (miRNA). J Biomed Biotechnol. 2006; 2006(4):26818. View in: PubMed

MicroRNA protocols. Perspectives. Methods Mol Biol. 2006; 342:351-8. View in: PubMed

Gene silencing in vitro and in vivo using intronic microRNAs. Methods Mol Biol. 2006; 342:295-312. View in: PubMed

MicroRNA: fine-tunes the function of genes in zebrafish. Biochem Biophys Res Commun. 2005 Sep 16; 335(1):1-4. View in: PubMed

Asymmetry of intronic pre-miRNA structures in functional RISC assembly. Gene. 2005 Aug 15; 356:32-8. View in: PubMed

Intronic microRNAs. Biochem Biophys Res Commun. 2005 Jan 21; 326(3):515-20. View in: PubMed

Intron-derived microRNAs--fine tuning of gene functions. Gene. 2004 Nov 10; 342(1):25-8. View in: PubMed

Complementary DNA libraries: an overview. Mol Biotechnol. 2004 Jul; 27(3):245-52. View in: PubMed

Gene expression in precursor cells of prostate cancer associated with activin by combination of subtractive hybridization and microarray technologies. Biochem Biophys Res Commun. 2004 Jan 2; 313(1):104-9. View in: PubMed

Combinational therapy for potential HIV-1 eradication and vaccination. Int J Oncol. 2004 Jan; 24(1):81-8. View in: PubMed

A novel RNA splicing-mediated gene silencing mechanism potential for genome evolution. Biochem Biophys Res Commun. 2003 Oct 24; 310(3):754-60. View in: PubMed

Truncated Bcl-2, a potential pre-metastatic marker in prostate cancer. Biochem Biophys Res Commun. 2003 Jul 11; 306(4):912-7. View in: PubMed

mRNA/cDNA library construction using RNA-polymerase cycling reaction. Methods Mol Biol. 2003; 221:129-43. View in: PubMed

Assessment of the quality of mRNA libraries by agarose gel electrophoresis. Methods Mol Biol. 2003; 221:155-9. View in: PubMed

Complementary DNA libraries: an overview. Methods Mol Biol. 2003; 221:1-12. View in: PubMed

Future perspectives. Methods Mol Biol. 2003; 221:311-29. View in: PubMed

Subtractive cloning of differential genes using RNA-PCR. Methods Mol Biol. 2003; 221:253-9. View in: PubMed

Subtractive hybridization for the identification of differentially expressed genes using uracil-dNA glycosylase and mung-bean nuclease. Methods Mol Biol. 2003; 221:239-51. View in: PubMed

Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood). 2002 Feb; 227(2):75-87. View in: PubMed

Powered bySC CTSI